Type I interferon antagonism of the JMJD3-IRF4 pathway modulates macrophage activation and polarization.
Ming-Chin Lee K, Achuthan AA, De Souza DP, Lupancu TJ, Binger KJ, Lee MKS, Xu Y, McConville MJ, de Weerd NA, Dragoljevic D, Hertzog PJ, Murphy AJ, Hamilton JA, Fleetwood AJ.
Ming-Chin Lee K, et al. Among authors: hertzog pj.
Cell Rep. 2022 Apr 19;39(3):110719. doi: 10.1016/j.celrep.2022.110719.
Cell Rep. 2022.
PMID: 35443173
Free article.